元器件交易网讯 5月8日消息，据外媒报道，谷歌风投（Google Ventures）已完成最大医疗投资案，将为Flatiron Health提供1.3亿美元的融资。

　　Flatiron Health是一个汇集来源丰富的癌症患者数据的平台，可以帮助医生得出治疗方案。

　　谷歌风投合伙管理人比尔·马里斯（Bill Maris）表示谷歌风投一般不做1亿美元以上的投资，“但我们相信这个团队、产品，他们的工作对全人类有益。”

　　Flatiron Health成立于2012年，总部位于纽约，其软件产品汇集来源广泛的临床和基因组数据、治疗效果、医疗笔记、计费信息及其他数据，并将这些信息呈现给医疗专家。

　　融资将帮助Flatiron Health收购Altos解决方案公司，该公司一直在为医疗专家提供基于云技术的电子病历。但此次收购并不在条款之内。（元器件交易网毛毛摘译）

　　以下为原文：

　　Google Ventures Leads $130 Million Roundfor Flatiron Health

　　Google Ventures has made its largestmedical software investment yet, providing the bulk of a $130 million financingfor Flatiron Health, which aggregates cancer-patient data from a wide varietyof sources to help doctors make treatment decisions.

　　Fortune earlier reported Flatiron wasraising a nine-digit round led by Google Ventures.

　　“We don’t generally make investments of $100-plus million,” said BillMaris, managing partner with Google Ventures. “When we do make an investment ofthis size, it means we really believe in the team, and the product, and thegood that it can do for the world.”

　　Only 4% of cancer patients participate inclinical trials, the company says, meaning that information about treatmentsand patient outcomes for 96% of patients is not easily accessible.

　　New York-based Flatiron, founded in 2012,makes software that taps a wide variety of sources to aggregate clinical andgenomic data, information on patient outcomes, doctors’ notes, billinginformation and other data, and presents the information to oncologists.

　　Doctors pondering a course of treatment forcancer patients use Flatiron to review other cases, and can see what outcomesvarious treatments have brought in the past, Maris said. Flatiron complies withprivacy laws, meaning that doctors using the platform do not learn theidentities of patients who are not their own.

　　Between 500 and 1,000 oncologists arecurrently using Flatiron’s data platform, said Flatiron co-founder NathanielTurner, who with co-founder Zach Weinberg sold their previous company, InviteMedia, to Google in 2010.

　　The new funding enables Flatiron to acquireAltos Solutions, a company offering cloud-based electronic medical records foroncology. Terms of the acquisition were not disclosed.

　　By adding Altos’ technology, doctors willhave access to the Flatiron database as they treat patients, enteringinformation into their electronic medical record, Maris said.

　　“This acquisition of Altos is like rocket fuel for Flatiron,” Marissaid. “Here you have two companies with very complementary technologies, bothworking in oncology. It’s a significant step forward for cancer care.”

　　Altos, which is not funded by venturecapitalists, has some 1,300 clinicians regularly using its electronic healthrecords, said Flatiron’s Turner. The company’s staff of 60 will join Flatironwhen the deal is finalized by the end of this month, he added.

　　Flatiron also plans to hire as many as 30more staff, many of them engineers, by the end of the year, he said.

　　Google Ventures has targeted medicalsoftware companies with a Big Data focus with several of its investments. Thefirm has backed DNAnexus Inc., which brings analytics to genomic information inan attempt to build the world’s first searchable archive of DNA information. Ithas also backed Foundation Medicine, which uses big-data tools to analyzeturmors, and Predilytics Inc., which offers health insurers a tool to trackhospital discharges and readmissions.

　　Dow Jones VentureSource records show thatthe Flatiron Health deal is the fourth largest round Google Ventures hasparticipated in. The firm confirmed it’s the largest medical software deal.

　　Flatiron Health previously raised an $8million Series A round from Google Ventures, First Round Capital, Great OaksCapital, IA Ventures, Lab Corp, Social+Capital Partnership, SV Angel and otherangel investors, VentureWire records show.